ABSTRACT
The occurrence of rhabdomyolysis during statin treatment for dyslipidemia is a well-known side effect. However, the differential diagnosis of rhabdomyolysis is large. We report on a patient treated with statin who presented a rhabdomyolysis. The persistence of laboratory abnormalities allowed to discover a metabolic rhabdomyolysis, namely a carnitine palmitoyltransférase II deficiency. The diagnosis of the genetic abnormality allows to modify the therapeutic care.
Subject(s)
Carnitine O-Palmitoyltransferase/deficiency , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Rhabdomyolysis/diagnosis , Rhabdomyolysis/genetics , Atorvastatin , Heptanoic Acids/adverse effects , Humans , Male , Middle Aged , Pyridines/adverse effects , Pyrroles/adverse effectsABSTRACT
Phase-sensitive order parameter symmetry test experiments are presented on the electron-doped high-T(c) cuprate Nd(2-x)Ce(x)CuO(4-y). These experiments have been conducted using zigzag-shaped thin film Josephson structures, in which the Nd(2-x)Ce(x)CuO(4-y) is connected to the low-T(c) superconductor Nb via an Au barrier layer. For the optimally doped as well as for the overdoped Nd(2-x)Ce(x)CuO(4-y), a clear predominant d(x2-y2)-wave behavior is observed at T=4.2 K. Both compounds were also investigated at T=1.6 K, presenting no indications for a change to a predominant s-wave symmetry with decreasing temperature.
ABSTRACT
In order to evaluate the effect of the acute viral hepatitis on arterial blood flow we performed duplex Doppler US on 30 patients with acute viral hepatitis (AVH) and compared the results with those obtained on 20 normal volunteers. Hepatic artery flow (HAF) was significantly increased with the patients suffering from acute viral hepatitis. The data obtained show that the increase of arterial blood flow is not always associated with the increase of arterial velocities. We could put in evidence the presence of the hepatic artery response to altered portal blood flow (arterial buffer) during a AVH. If the increase of HAF is absolutely necessary for recovery from hepatitis, excessive increase of HAF seems to increase the time of recovery. In our study, the evolution of acute viral hepatitis was good when the HAF values did not exceed 65% of liver supply. The increase of arterial blood flow over 65% seems to limit the portal supply of the liver and in this way the amounts of regenerating substances which bathe the liver cells. The HAF value plays an important role in acute viral hepatitis evolution, so that the exploration of HAF and hepatic artery velocities may be a reliable examination in order to monitor the evolution of this disease.
